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ABSTRACT
Introduction The perioperative period is high risk
for older adults. Depression and anxiety are common
perioperative problems, frequently coexisting with
cognitive impairment. Older patients with these conditions
are more likely than younger patients to experience
postoperative delirium, long hospital stays, poor quality of
life and rehospitalisation. These experiences can, in turn,
exacerbate anxiety and depressive symptoms. Despite
these risks, little is known about how to treat perioperative
anxiety and depression among older adults.
Methods and analysis We designed a feasibility study
of a perioperative mental health intervention bundle
to improve perioperative mental health, specifically
depression and anxiety. The overarching goals of this
study are twofold: first, to adapt and refine an intervention
bundle comprised of behavioural activation and medication
optimisation to meet the needs of older adults within three
surgical patient populations (ie, orthopaedic, oncological
and cardiac); and second, to test the feasibility of study
procedures and intervention bundle implementation.
Quantitative data on clinical outcomes such as depression,
anxiety, quality of life, delirium, falls, length of stay,
hospitalisation and pain will be collected and tabulated
for descriptive purposes. A hybrid inductive–deductive
thematic approach will be employed to analyse qualitative
feedback from key stakeholders.
Ethics and dissemination The study received approval
from the Washington University Institutional Review
Board. Results of this study will be presented in peer-
reviewed journals, at professional conferences, and to our
perioperative mental health advisory board.
Trial registration number NCT05110690.

INTRODUCTION
Americans undergo an average of nine
surgeries in their lifetime.1 Over 51 million
surgeries are performed in the USA each year,
with older adults representing approximately
half of all surgical patients.2 The perioperative period—encompassing preoperative
(before surgery), intraoperative (during
surgery) and postoperative (after surgery)

STRENGTHS AND LIMITATIONS OF THIS STUDY
⇒ This perioperative mental health intervention bundle

comprised of behavioural activation and medication optimisation will be the first of its kind focused
on improving cognitive and mental health of older
patients who undergo surgery and manage their
symptoms of depression and anxiety along the
perioperative continuum.
⇒ This study will iteratively adapt and test the feasibility of implementing a patient-centred perioperative
mental health intervention bundle with psychological and pharmacological optimisation components.
⇒ Our approach will provide feasibility data on whether
we can: (1) enrol patients, (2) collect and refine data
collection methods, (3) implement the intervention
bundle within the perioperative context, (4) tailor the
intervention bundle for the three surgical cohorts
and (5) determine whether a future randomised
effectiveness-implementation trial of the intervention bundle in the perioperative setting is feasible.

phases—is a high-risk and vulnerable time for
older patients. Older patients are at increased
risk for postoperative morbidity and mortality
compared with younger adults.3–10 Anxiety
and depression in older surgical patients
increase the risk of postoperative complications, including short-term functional dependence and falls,11 postoperative delirium,12
opioid misuse,13 14 decreased quality of life15
and readmission. A meta-
analysis of over
200 000 patients undergoing cardiac surgery
revealed significantly increased mortality risk
among individuals with perioperative depression and anxiety.16
There have been efforts to reduce perioperative risks in older adults by optimising
physical health prior to surgery (prehabilitation), implementing protocolised pathways
during the surgical hospitalisation and also
promoting postoperative rehabilitation (eg,
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enhanced recovery). However, no corresponding perioperative interventions have been developed to address
cognitive and mental health and well-
being. In other
words, we lack effective interventions tailored for older
surgical patients, in spite of the high prevalence of depression and anxiety in this population,17 frequent co-occurring cognitive impairment and detrimental impact on
surgical recovery.18
In our prior needs assessment interview study with
older surgical adults diagnosed with anxiety and depression and their treating clinicians,18 we found that older
surgical patients had varying care experiences, depending
on their symptoms in the perioperative setting. Fear and
uncertainty leading into the surgery and poor management of their depression and anxiety medications postoperatively were of key concern. Clinicians treating
this population similarly noted that patients have a fear
of surgery, experience acute pain, and can suffer from
postoperative neurocognitive disorders. They were also
worried that central nervous system active medications
could worsen outcomes, yet many patients reported
taking these medications at a subtherapeutic dose of
medications for mental health, suggesting a need to optimise their dosage. However, clinicians reported concerns
that stopping these medications could lead to withdrawal
symptoms, but maintaining them could worsen their
cognitive and mental health impairment.
Patients and clinician stakeholders emphasised the
need for a perioperative intervention bundle to address
these issues and argued for a bundle encompassing
psychological components that are behavioural, simple,
interactive and engaging, and pharmacotherapy components that can minimise the risk of psychiatric medication withdrawal symptoms and improper dosages during
perioperative care. They also recommended that such
a mental health intervention bundle would be effective if it started preoperatively to assist with preparation
for surgery and continued postoperatively to enhance
recovery after surgery.18
Researchers have examined the use of counselling,
cognitive–behavioral therapy (CBT), and other psychological treatments (eg, relaxation, mindfulness and
supportive therapy) to promote the mental well-being
of younger surgical patients.19–21 For example, Li and
colleagues20 found that a psychological intervention
provided to patients with cancer throughout the perioperative period was associated with decreased depressive
symptoms and anxiety postoperatively. Similarly, research
with patients undergoing orthopaedic surgery suggests
that perioperative psychological education and counselling improved both psychological function,21 22 as well
as physical function.21 In addition, studies suggest that
a combination of pharmacological and psychotherapy
is more effective at treating anxiety and depression in
older adults than monotherapy23–28 and may be considered more acceptable to older adults,25 suggesting the
need for an intervention bundle that combines psychotherapeutic and pharmacological treatment. Older adults

often take many medications, and in the perioperative
period, there is heightened risk of adverse drug reactions
and drug–drug interactions.29 Medication optimisation
and deprescription can help with reduction or elimination of potentially inappropriate medications (such as
benzodiazepines), in conjunction with appropriate antidepressant dosing and continuation across outpatient
and inpatient care transitions.
Our team has previously demonstrated the effectiveness of CBT and behavioural activation for depression
in medically ill populations,30–35 and for anxious older
adults with comorbid depression,28 and also of medication optimisation and deprescription for older adults36 in
the perioperative setting.37 Informed by our prior work
(see table 1 for features, clinical evidence and rationale),
we propose to develop a perioperative mental health
intervention bundle (hereafter referred to as the intervention bundle) encompassing two integrated components:
behavioural activation (psychotherapy) and medication
optimisation and deprescription (pharmacotherapy) for
older surgical patients with anxiety and depression.
Developing the intervention bundle: adaptation process prior
to feasibility evaluation
In preparation for this study, we organised an internal advisory board (IAB), comprised of older surgical patients,
their caregivers, clinicians and researchers, to propose
initial adaptations to the intervention bundle, informed
by a collaborative planning approach. This approach
integrates community-
based participatory research
with intervention mapping to guide intervention planning, implementation and evaluation.38 39 Intervention
mapping is a step-by-step process that uses activities (eg,
group discussions) and tools (eg, logic models) to develop
a roadmap to inform the adaptation and implementation
of interventions and has been used in a range of interventions and health issues.40 The IAB members participated
in three workshop sessions, which provided us with an
interactive forum to garner their perspectives and experiences with mental healthcare management and its impact
on preparation before surgery and recovery after surgery.
The sessions were moderated by an experienced qualitative researcher and focused on two key goals: (1) ascertain needs and design requirements for an intervention
bundle to address the barriers associated with effective
perioperative mental healthcare management and (2)
suggest modifications to an intervention bundle to align
with older surgical patient care pathways. We also held
weekly meetings with interventionists including social
workers, pharmacists, psychiatrists and behavioural scientists to refine and adapt the intervention bundle, based
on the IAB input such that our bundle components
integrates within the perioperative context and address
needs of older adults. Transcripts of these sessions and
the weekly meetings were thematically analysed to inform
our preimplementation adaptations to ensure effectiveness, feasibility, acceptability and overall satisfaction of
the intervention bundle.
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Table 1 Details on adapted perioperative mental health bundle components
Intervention bundle

Behavioural activation

Medication optimisation

Target

Patients

Clinicians and patients

Interventionist

Perioperative wellness partner.

Perioperative wellness partner follows an algorithm
for medication optimisation and works alongside with
pharmacists and a geriatric psychiatrist.

Description

A behavioural intervention helping depressed and
anxious patients by engaging them in reinforcing
activities or activities that are meaningful and guided
by their personal values.66

A pharmacological intervention to adjust suboptimal
doses of antidepressants, ensure continuation
of antidepressants during transitions of care and
deprescribe medications that are harmful to older
adults.67 68

Features

Flexible component of cognitive–behavioral therapy
(CBT) and standalone treatment in which the
therapist helps a patient generate a list of pleasant,
reinforcing activities and cocreates action plans.
Patient-centred treatment, in which the patient
chooses the modality (ie, which activities to engage
in).

Medication optimisation consists of a simple set
of principles: identify the patient’s likely need for
a medication adjustment, advise their provider to
make the adjustment, and assess response29 69 70
Additionally, it involves a review of current medications
(including over the counter) for those that are eligible
for deprescribing, including strong centrally acting
anticholinergic and antihistaminergic drugs and
benzodiazepines.

Rationale for including

Comparative efficacy and non-inferiority trials
have shown that behavioural activation is about
as effective as comprehensive CBT, and it can be
delivered by less highly trained staff.
Trials in medically ill patients have emphasised
behavioural activation because it complements
medically indicated physical activation and exercise
goals, and it is feasible and acceptable.31

Medication optimisation is a cardinal rule in treatment
guidelines for depression.71
Antidepressants are often prescribed at
subtherapeutic doses and then not adjusted for
response.72 Suboptimal dosing is a main reason for
these drugs’ low effectiveness in the real world.73
Strong centrally acting anticholinergic and
antihistaminergic drugs and benzodiazepines are
‘low-hanging fruit’ for deprescribing as their harms
outweigh benefits.74 They are harmful perioperatively,
increasing falls and delirium.75–78

Core active
components

►
►
►
►

Personalised rationale identification.
Values and goals assessment.
Activity scheduling.
Activity monitoring.

► Review of medication list by wellness partner on

first visit prior to surgery.

► Determine the indication, duration of use, dose and

frequency of the medications of interest.

► Evaluate each medication’s eligibility for
►
►
►
►
►

Modifiable components ► Selected behavioural activation activities:
depending on patient needs and preferences.
► Timing: preoperative and postoperative phases.
► Format: 1:1 session in-person/telephone/online.
► Duration: 20–30 min.
► Frequency: 1–4 (presurgery); 2–12 (postsurgery).
► Setting: home (telephone/online) and hospital.

optimisation or deprescription.
Discuss with medication optimisation team.
Get buy-in from patient to contact initial prescriber.
Communicate recommendations to the patient.
Weekly review of any new medications.
Ensure that any medication optimisation changes
are reconciled during transitions of care and that
the agreed-upon changes are implemented both
preoperatively and postoperatively.

► Timing: preoperative and postoperative phases

►
►
►
►

(start as early as possible). While in-hospital, the
pharmacy team coordinates with the hospital
team to ensure that medication changes that were
introduced preoperatively are maintained in-house
and that no new inappropriate medications are
initiated.
Format: 1:1 session in-person/telephone/online;
then contact with the clinicians.
Duration: 5 min.
Frequency: 1–4 (pre); 2–12 (post).
Setting: home (telephone/online) and hospital.

Findings from this work pointed to three major design
requirements and adaptations: first, the intervention
bundle be initiated prior to surgery and continued after
surgery to cover two phases (see figure 1): preoperative:

focusing on improving patient preparedness for surgery, and
postoperative: focusing on enhancing recovery (see section
on components of the intervention bundle; appendices A and B for the detailed SOPs). Second, the term
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Figure 1

Adaptation process of the perioperative mental health intervention bundle. IAB, internal advisory board.

medication optimisation was suggested for the pharmacological component. Third, the term, perioperative wellness partner was formulated to refer to interventionists.
Interventionists
The interventionists, referred to as perioperative wellness partners are masters-
level clinicians trained in
behavioural activation using the material developed by
Puspitasari and colleagues.41 They will deliver the intervention bundle with oversight from study team members
with knowledge in both medications and systems of care
for perioperative management, including pharmacists, a
psychologist, a geriatric psychiatrist and a licenced clinical social worker.
Components of the intervention bundle
Behavioural activation
Figure 2 presents a model of behavioural activation
for surgery. Behavioural activation will be practised
according to Kanter’s Behavioral Activation for Depression.42
Behavioural activation as the core intervention allows
for uniformity across participants yet enough flexibility
for the actual components of behavioural activation to
be individually adapted based on patient preferences.
In addition to the core components of behavioural activation (table 1), study participants in collaboration with
their perioperative wellness partner will be able to adapt

the intervention by choosing activities, per their preference, with demonstrated benefit in improving depression and anxiety symptoms in older surgical patients.43 44
The behavioural activation process will be guided by the
Behavioural Activation Standard Operating Procedure
(BA SOP) (online supplemental appendix A), which will
be adapted and calibrated as needed during the feasibility study.
Medication optimisation
Patient antidepressant medications will be reviewed with
the patient by the perioperative wellness partner, and
based on the decision algorithm, are optimised by our
study team of interventionists including a psychiatrist,
psychologist and pharmacists. The medication optimisation process will be guided by the Medication Optimisation Standard Operating Procedure (MO SOP) (online
supplemental appendix B), which will be adapted as
needed during the feasibility study.
In this paper, we present a protocol for a prospective
study to further adapt and test the feasibility of implementing our intervention bundle to reduce anxiety and
depressive symptoms in older surgical patients undergoing cardiac, oncological and orthopaedic surgeries at a
large academic medical centre. Towards this end, we will
use frameworks from implementation science to capture

Figure 2 Behavioural activation model for the perioperative setting. (A) Behavioral activation – symptom cycles. (B) Behavioral
activation – interrupting symptom cycles.
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the nuances and complexities unique to each patient
population/setting that will inform our adaptation
and implementation of the mental health intervention
bundle. The Consolidated Framework for Implementation Research (CFIR)45 is a well-operationalised, multilevel determination framework derived from theory
that will help us identify the determinants (ie, barriers
and facilitators) that affect the implementation process
across the three settings and populations. The framework has 39 constructs across five domains: intervention
characteristics, inner setting, outer setting, characteristics
of individuals and implementation process, which help
elucidate the context and factors that affect implementation and intervention bundle evaluation. The Framework
for Reporting Adaptations and Modifications-Expanded
(FRAME)46 will allow us to systematically track all adaptations to the flexible components of the intervention
bundle to ensure the feasibility, fit and relevance in
older surgical patients, without compromising its core
components.
Study objectives
The study objectives are summarised below:
1. Examine the feasibility of implementing a patient-
centred intervention bundle for older surgical patients
with clinically significant symptoms of depression and/
or anxiety.
2. Iteratively test and adapt the intervention bundle and
the implementation plan to make it patient centred,
in response to the needs/demands of older surgical
patients with clinically significant symptoms of depression and/or anxiety along the preoperative and postoperative phases.
3. Identify multiple stakeholder perspectives and experiences with the intervention bundle with specific emphasis on its implementation barriers, enablers and
implementation strategies to ensure its reach, uptake
and sustainability in perioperative settings.
4. Demonstrate the fidelity, acceptability and appropriateness of the intervention bundle delivery for older

surgical patients with clinically significant symptoms of
depression and/or anxiety.
5. Assess the feasibility of study procedures including patient recruitment, screening, outcome assessments and
intervention materials for older patients.
Following this study, we will evaluate the effectiveness
and implementation potential of our adapted intervention bundle using a randomised controlled trial.
METHODS
Study design and approach
A mixed methods (quant+qual) approach supported by
a parallel convergent study design will be followed; this
will allow us to collect quantitative and qualitative data
simultaneously) and merge the data in order to compare
and interpret together.47 Quantitative data on anxiety and
depression, quality of life, in-hospital delirium incidence,
postdischarge falls, medications, length of stay, all-cause
rehospitalisation, pain, patient experience and shared
decision making will be collected. Qualitative surveys and
interviews will help us to assess participants’ feedback and
experiences about factors affecting implementation and
use of the bundle.
Study participants and recruitment procedure
Patient participants include older adults undergoing
cardiac, orthopaedic or oncology surgery receiving treatment at a large teaching hospital serving a catchment area
including both urban and rural patients in a Midwest state
in the USA. We will also invite their caregivers to participate in this study. Table 2 provides information about
the expected enrolment numbers, inclusion criteria and
exclusion criteria of participants.
Patient participants will be recruited via three paths:
Epic Electronic Health Record (EHR) report, clinician
referral and self-referral (figure 3).
With the patients’ consent, caregiver participants will be
recruited via two paths: patient referral to either contact
the study team or share the caregiver’s phone number

Table 2 Enrolment, inclusion criteria and exclusion criteria by type of participant
Participant type

Expected enrolment

Patients

8–10 cardiac surgery
► ≥60 years of age on the day of surgery.
patients.
► Scheduled major orthopaedic surgery, or
8–10 orthopaedic
major surgical resection of a thoracic or
surgery patients.
abdominal malignancy, or major cardiac
8–10 oncological surgery
procedure.
patients.
► Clinically significant depression or
anxiety symptoms screened by the
Patient Health Questionnaire Anxiety and
Depression Scale79 ≥10.†
► Identified by patient as a family member
24–30 caregivers will
or friend who cares for the patient as
be recruited alongside
needed to support health and safety.
patient participants.

Caregivers

Inclusion criteria

Exclusion criteria*
► Estimated life expectancy <12 months.
► Unable to read, speak and understand

English.

► Current alcohol or other substance

abuse.

► Severe cognitive impairment screened

by the Short Blessed Test >10.

► Acutely suicidal.
► Age ≤18 years.

*Patients may meet any one or more of the exclusion criteria to become ineligible to participate.
†Patients must meet all eligibility criteria to participate.
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Figure 3

Patient recruitment paths.

such that the study team will contact caregivers by phone
or mail and invite them.

orientation, registration and attention. The SBT has
demonstrated good test-retest reliability.57

Assessment measures
At enrolment, a research coordinator will administer a
battery of assessments to characterise patient participants
and their current condition.

Ultra-Brief Confusion Assessment Method (UB-CAM)
This two-
item test58 is used for a quick assessment of
delirium using items from the 3 min diagnostic interview
for confusion assessment method (3D-CAM).59 Patients
are asked to state the day of the week and months of the
year backwards. If the UB-CAM is positive, the assessment
continues with the full 3D-CAM.

Patient baseline measures
Demographics
The following characteristics will be collected: age, sex,
race/ethnicity, education level, employment status,
psychiatric diagnosis, substance use and psychotropic
medications.
Medical history of comorbidities
Patient medical history and comorbidities will also be
collected.
Pain
The Brief Pain Invento (BPI) is a well-validated 11-item
measure of pain severity and interference in pain,48–53
including after orthopaedic,54 oncological55 and cardiac
surgery.56 Three questions from the BPI will be used to
assess pain, including whether the patient is diagnosed
with chronic pain, whether they experience pain daily
in the past 3 months and if they have been experiencing
pain in the past week related or unrelated to their surgery.

Medication list
The research coordinator and perioperative wellness
partner will review the patients’ medications from the
EHR and confirmed with the patient at the initial intervention visit, capturing the medication name, dose, units,
frequency, start date, stop date and indication, where
appropriate.

Short Blessed Test (SBT)
The SBT, sometimes called the Orientation-
Memory-
Concentration Test, is a six-item scale frequently used to
assess dementia within patients across three dimensions:

Intervention adaptation measures
Intervention fidelity
Data related to intervention fidelity to examine the
extent to which an intervention bundle is carried out
by our perioperative wellness partner as intended and
consistently across different settings, and patients will be
tracked as adherence to core components of the intervention bundle, quality of delivery and participant responsiveness.60 All sessions will be audio recorded and reviewed by
the supervising perioperative wellness partner (ie, trained
in intervention bundle and is fidelity certified). Additionally, all intervention sessions will be reviewed and rated
for fidelity by a team of researchers with training in the
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intervention bundle (licenced social worker and research
assistant). Written and/or verbal feedback will be shared
with our wellness partners.
Adaptations to the intervention bundle and its implementation
Adaptations are thoughtful and deliberate alterations to
the flexible components of the intervention bundle, the
format or delivery of the intervention bundle by perioperative wellness partners in order to improve its fit or
effectiveness in a given context.46 Other changes may
happen to the delivery of the intervention. Data on such
adaptations and modifications will be collected during:
(A) weekly case review intervention meetings where wellness partners will report on any changes they made to
the intervention content and delivery method and their
underlying rationale to implement that change and (B)
periodic reflection meetings61 led by implementation
scientists with the wellness partners where they will be
asked to reflect on any modifications made deliberately
and proactively, in response to unanticipated challenges
in a given session or context.
The Behavioral Activation for Depression Scale – Short
Form,62 or BADS-SF, is our measure of target engagement. The BADS-SF is a nine-item questionnaire derived
from the original BADS63 questionnaire that consists of 25
items across four subscales: activation, avoidance/rumination, work/school impairment, and social impairment.

It is frequently used to measure changes in behavioural
activation levels following treatment.
Outcome measures for feasibility study
Outcomes for the feasibility study and their timepoints
are provided in table 3. We will be assessing the reach
of our study and our intervention bundle (ie, primary
outcome), the feasibility of collecting depression and
anxiety outcome planned for our randomised control
trial (ie, secondary outcome) and implementation
potential of intervention bundle and other outcomes
such as quality of life and readmissions (ie, exploratory
outcomes).
Data related to participant recruitment, retention and
assessments will be collected to help us ascertain if any
modifications to the study procedures need to be made
to inform sample size estimates and power calculations in
subsequent randomised controlled trial studies.
To obtain participant perspectives on the intervention
bundle, we will conduct semistructured interviews with
patients and caregivers, and the topics of discussions will
be guided by the CFIR constructs. The interviews will
explore the participants’ perceptions, attitudes and experiences with the intervention bundle, intervention bundle
acceptability and detailed accounts of participants’ experiences after the intervention has been stopped with
regards to intervention sustainability and maintenance.

Table 3 Feasibility study outcomes and potential study primary and secondary outcomes for planned randomised controlled
trial (RCT).
Outcomes

Specific measure: description

Source

Timepoint

Reach
(primary)

Reach of the study: patients who agreed to participate in the study out of
total eligible to participate.
Reach of the intervention bundle: patients who completed the
interventions out of patients who agreed to participate in the pilot.

Electronic health
record and research
data warehouse

End of study

Completeness of planned
RCT primary outcome
data collection at specified
timepoints
(secondary)

Defined as a percentage of instrument or data fields completed for:
Patient Health Questionnaire Anxiety and Depression Scale79: 16-item
scale with components of the Patient Health Questionnaire-9 and
Generalised Anxiety Disorder Scale (collected at baseline, 1 month, 3
months)

Research data
warehouse

End of study

Implementation potential
(exploratory)

Acceptability, appropriateness and feasibility of the interventions: the
Surveys
acceptability of intervention measure, the intervention appropriateness
measure and the feasibility of intervention measure.80 Each survey has
four items in a Likert scale ranging from completely disagree to completely
agree.

End of study

Completeness of planned
RCT secondary outcomes
data collection at specified
timepoints
(exploratory)

We will be measuring the completeness of data collection for the following Research data
potential secondary outcomes for the planned RCT secondary outcomes: warehouse
► Quality of life (collected at baseline, 1 month, 3 months).
► In-hospital delirium incidence (collected at baseline, in-hospital/
postoperatively).
► Postdischarge falls (collected at baseline, 1 month, 2 months, 3
months).
► Medication optimised and adherence to medications (collected at
baseline, 1 month, 3 months)
► Length of stay (both hospital and intensive care unit).
► All-cause rehospitalisation (collected in the hospital/postoperatively, 1
month, 3 months).
► Persistent postsurgical pain (collected at 1 month, 3 months).
► Patient experience (collected at end of study).
► Shared decision making (collected at end of study).

End of study

Note: the surveys and questionnaires will be administered via email or research coordinators over the telephone.
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These insights will inform whether the intervention
bundle needs to be changed or adapted before our future
trials. Interviews will be conducted via Zoom or telephone
and will be digitally recorded and transcribed verbatim.

Caregivers (participating in semistructured interviews via
Zoom/phone or in-person) will be consented verbally
or with a written consent, depending on participant
convenience.

Data management and analysis plan
Data management
This study will be conducted under appropriate Washington University Institutional Review Board guidance
and use only Institutional Review Board-approved study
procedures and instruments. A unique patient number
will be assigned at enrolment and used wherever possible
on the case report forms to identify data, minimising use
of patients’ names or personal identifiers in data.

Harms
This study involves minimal risk to subjects. Unlikely but
potential risks include errors in medication recommendations; however, this risk is mitigated by the utilisation
of a multidisciplinary group of experts agreeing on the
recommendation and ongoing check points throughout
the intervention process to ensure recommendations are
correct and free from error. Additional risks include medication withdrawal symptoms as a result of the intervention recommendation and breach of confidentiality. The
risk of medication withdrawal (ie, from benzodiazepines)
is mitigated by slowly tapering rather than stopping these
medications. If a participant endorses suicidal ideation,
intent or plan, the coordinator and perioperative wellness partners are trained to follow an operationalised
protocol (see online supplemental appendices A and B)
that has been developed to manage high-risk participants
in other studies of depressed participants potentially
at risk for suicide. This protocol has already been used
successfully by members of the research team to manage
acutely suicidal patients. Patients will be encouraged to
check with their physician if there is any question about
the safety of any physical activities that are included in the
behavioural activation plan. It is possible that the participant may feel uncomfortable completing the surveys
or participating in the study sessions. The study sessions
and interview can be discontinued at any time, and the
patient may refuse to answer any questions that he or she
does not wish to answer.
We will monitor for breaches of confidentiality and
other adverse events on an ongoing basis. Once we
become aware of a reportable adverse event, the event
will be reported to Human Research Protection Office
and Quality Assurance and Safety Monitoring Committee
(QASMC) according to institutional guidelines. This
study does not require QASMC audit or submission of
DSM reports. Should any unexpected serious adverse
events occur, our study protocol will be modified to
prevent other similar events.

Data analysis
Quantitative data collected for the outcome measures for
the feasibility study will be tallied and summarised using
descriptive statistics. Completion of data collection will be
described as a percentage of the instruments completed.
The primary outcome of anxiety and depression for the
planned RCT will be tabulated for descriptive purposes.
Fidelity and adaptation data will be analysed using
open coding and the FRAME analytic framework to
help track any adaptations to intervention bundle and
delivery.46 Interview data will be analysed using an inductive–deductive thematic analysis.64 After reading the
transcripts multiple times for familiarity, research team
members will openly code using data-driven codes and
then using CFIR-driven codes. Codes will be compared
across the data to identify repeated and interrelated
concepts and categories, and subthemes will be formed.
Similar subthemes will be grouped over multiple rounds
of review to generate overarching themes out of significant patterns between interviews.
Patient and public involvement
In preparation for this study, we organised an internal
advisory board with surgical patients, caregivers, clinicians
(eg, physicians, nurses, pharmacists and social workers)
and institutional leaders focused on patient experience
to adapt our intervention bundle. Through the internal
advisory board meetings, we sought to ensure that the
intervention bundle facilitates patient preparedness for
surgery during the preoperative period and enhances
recovery during the postoperative period, coordinating
and communicating with inpatient clinicians and to evaluate whether the intervention methods are practical and
appropriate for the patient populations and clinicians,
without affecting perioperative workflow.

Internal auditing for data quality
The methodology core team meets biweekly with the
research coordinators and data manager to review the
study report on study enrolment, recruitment, monitor
data quality and discuss the study progress and any issues
raised by the participants.

ETHICS AND DISSEMINATION
Participant consents
Patients who meet all eligibility criteria and provide
written informed consent will be enrolled into the study.
Patient consent will be obtained via a paper collected by
mail or in person or by secure REDCap link to e-consent.

Data safety and monitoring plan
The specific monitoring plan for this investigation is
commensurate with the risks and the size and complexity
of the studies planned. Given the nature of the protocol,
the risks are likely limited to breach of confidentiality.
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DISSEMINATION
The feasibility study results will be disseminated at scientific
meetings and peer-
reviewed publications. Additionally,
the results will be presented to our perioperative mental
health internal and external advisory board consisting
of patients, clinicians, nationally recognised researchers
(psychiatry, health services and pain medicine) and
hospital administrator stakeholder groups to determine
which components of the intervention and its delivery
to preserve, which adaptations to carry forward and how
to advance with the randomised controlled trials. The
Washington University Centre for Perioperative Mental
Health website (https://perioperativewellness.wustl.
edu/) will be used to introduce the intervention bundle
to patients and clinicians alike. To accelerate the dissemination efforts, the Centre will use online communication
channels including the Centre’s webpage, popular news
media, social media, webinars and patient and family
community networks. As per the National Institute of
Mental Health sponsor guidelines, we will also be sharing
the deidentified data to ClinicalTrials.gov.

DISCUSSION
To our knowledge, the proposed perioperative mental
health bundle will be the first of its kind to assist older
surgical patients in managing their perioperative mental
health. Current interventions need to be adapted and
tested for older surgical patients, who face additional
unique challenges such as frailty, multimorbidity with
occurring cognitive and physical impairments, and
co-
polypharmacy that can also impact their mental health
and well-being.11 65
The study protocol will adapt the intervention bundle
comprised of behavioural activation and medication
optimisation and provide evidence on the feasibility of
testing the bundle as a potential intervention for anxiety
and depression in older surgical patients. In addition,
this study will provide feasibility data on implementing
the bundle successfully within perioperative settings.
Despite the empirical evidence available on behavioural
activation and medication optimisation, there are unique
challenges to using and implementing these interventions for the perioperative population of older adults,
in perioperative settings notable for their complexity.
To the best of our knowledge, the protocol is the first
to adapt and examine the feasibility of the intervention
bundle within the perioperative setting for older surgical
patients. We will identify components of our intervention
bundle and its delivery mechanism that can be common
across the three different surgical populations, and also

components that are unique for a particular population, and further for a particular patient based on their
surgical pathways.
Results from this mixed method study will inform the
following: first, findings related to experiences in participating in the intervention bundle, along with intervention
fidelity and adaptation tracking, will allow us to finalise
progress’ intervention
modifications to our initial ‘in-
bundle, resulting in a more patient-centred bundle that
meets the needs and preferences of our diverse patients.
Second, findings will determine if the components of the
intervention bundle are feasible to be delivered in three
very different settings in terms of dose, timing and duration of intervention. Third, findings will lead to an adapted
intervention standard of procedure (SOP) that can guide
the delivery of the intervention bundle by perioperative
wellness partners and one that can be tested for fidelity
in our future effectiveness-implementation RCT. Fourth,
findings will offer an initial roadmap for adapting and
implementing patient-
centred mental health interventions that are likely to be accepted and used by multiple
stakeholders in the future. The intervention bundle adaptations performed in this study can be flexible enough
and tailored based on patient needs/surgical conditions
in diverse surgical settings while also maintaining the core
components of the bundle, leading to a higher potential
for scalability and sustainability in the long term. Use of
the implementation science frameworks offers us the lens
to examine the feasibility and acceptability of the intervention bundle ahead of time, in order to accelerate
the translation of the intervention bundle to usual care.
Lastly, the study will inform the design and conduct of
the planned randomised controlled trials in the three
surgical cohorts. This study provides us with an opportunity to identify and address unanticipated challenges with
our study procedures including recruitment methods,
engagement strategies, study design flaws and outcome
measurement challenges.
This study comes with several limitations, similar to
other feasibility trials. First, the sample sizes will be small
as the proposed study focuses only on the evaluation of
feasibility and implementation potential of the intervention bundle, thereby limiting the ability to detect changes
in outcomes. Second, the study does not include a control
condition, and hence we will not be making any conclusions about the intervention bundle effectiveness. Third,
results from this study are specific to our study setting
and population at an academic medical centre and may
not be generalised to other non-academic settings. Nevertheless, this study will demonstrate whether it is feasible
to: (1) recruit, (2) implement the intervention bundle in
the perioperative period and (3) track the outcomes of
interest, prior to conducting an RCT with a comparison
group that will determine the efficacy of patient-centred
intervention bundle in the three different surgical
populations.
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Trial status
This study is registered in Clinical Trials Registry
NCT05110690. Recruitment commenced during the last
week of November 2021, and the enrolment is expected
to conclude in March 2023.
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APPENDIX A Behavioral Activation Standard Operating Procedure (SOP)

Center for Perioperative Mental Health Intervention:
Behavioral Activation
Behavioral Activation (BA) is a flexible, patient-centered treatment. The Perioperative Wellness Partner
(study interventionist) supports the patient in engaging in activities of the patient’s choice to promote
their mental and physical wellness.
Behavioral Activation will be practiced according to Behavioral Activation for Depression by Jonathan
W. Kanter et al, in Treatment of Depression in Adolescents and Adults, copyright 2011.
Sessions will occur via zoom, telephone, or in person, per patient preference. Location of sessions will be
documented.
Sessions will begin no more than 30 days prior to scheduled surgery aiming for approximately 2 preoperative sessions. When the time between consent and surgery is less than 2 weeks, attempt 1 BA
session or brief introductory contact prior to surgery. Sessions will conclude approximately 90 days postoperative, aiming for participants to receive approximately 8-10 BA sessions. Sessions will typically
occur every two weeks but frequency can be increased to weekly to achieve 8-10 total sessions and per
patient needs, preference, and treatment goals. The duration is anticipated to be approximately 40 minutes
per session, but can be adjusted between 20 and 60 minutes depending on patient needs and treatment
goals. Session duration will be documented.
Core components are summarized below:
Personalized Rationale: The Perioperative Wellness Partner will develop a personalized rationale to
ensure each patient understands how Behavioral Activation could be helpful for them:
1. Assess and discuss negative life experiences (including the upcoming surgery, and any other
difficult circumstances). For context and to build upon strengths, assess and discuss positive life
experiences (what’s been going well lately).
2. Assess and discuss emotional and behavioral responses (what are they doing, not doing, doing
more of, doing less of in response to the negative life experiences? Are those responses causing
any problems?)
3. Validate emotional and behavioral responses as natural, normal, common.
4. Discuss symptom cycles and how behavioral responses can perpetuate problems. This is the idea
that our natural behavioral responses to a problem or symptom can sometimes make the problem
worse, or cause other problems.
5. Explain the goal of BA: activation as an alternative to the patient’s behavioral responses.
Changing what we do can change how we feel and think, even in difficult circumstances.
6. Seek feedback and verify understanding of the intervention rationale
7. Discuss interventionist role to coach, guide, and help think of strategies, acknowledging that there
will be challenges.
8. Throughout - use the patient’s language instead of jargon to discuss problems, responses, and
symptoms.
Assessment: conduct a concentrated, detailed assessment early in the treatment process.
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1. Values and long term goals: find out what matters to the patient, what their aspirations are.
2. Targets for meaningful activities:
Typically in BA, reinforcing activities – ones that are rewarding, pleasurable, meaningful and/or that
provide a sense of productivity or accomplishment. Another way to identify target activities is to ask
about personally important activities that the patient has discontinued or is doing less frequently than in
the past. These targets may be applicable in the perioperative setting. Targets for activities that may
be particularly helpful in the perioperative setting include:
- Activities that bring a sense of normalcy and help restore sense of identity
- Activities that distract from unproductive worry or rumination
- Activities that help with physically preparing or recovering from surgery
- Activities that promote social connection
- Activities that are cognitively engaging
3. How activities affect mood: gathering details on how the patient’s real-life day-to-day activities
impact their mood.
4. Avoidance: assessing whether there are things the patient has been avoiding; and whether there are
activities that serve as an escape or distraction from difficult feelings or activities.
5. Routine and routine disruptions: learning about the patient’s current and ideal daily routine
(sleep-wake, hygiene, eating habits, physical activity, work and/or chores) and any disruptions
affecting their normal routines and the reasons for disruptions. Even in the absence of routine
disruption pre-operatively, it is helpful to revisit post-operatively to assist in returning to healthy
daily routines.
6. Current psychosocial stressors: assess whether there are major current psychosocial stressors
impacting patient’s recovery, function, and ability to carry out activity scheduling goals (e.g., acute
grief, financial difficulties, problematic living situation, fraught relationship with primary
caregiver). Always maintain focus on actions the patient can take even in difficult circumstances.
Activity Scheduling: collaborative process between the patient and Perioperative Wellness Partner to
plan for helpful activities. Activity scheduling is concrete and considers the difficulty of the task in the
context of the patient’s life, including any acute or chronic physical limitations.
1. Collaboratively identify activities to work on
2. Consider difficulty of activity in the current context and break tasks into smaller parts if
needed
3. Schedule at least one activity concretely (what, where, when, with whom)
4. Problem solve any obstacles to activity completion
Pre-Operative Period: Ideally, both Behavioral Activation and Medication Optimization will begin
before surgery. This time can be used for assessment and learning the process of activity scheduling.
1. Assess emotional and behavioral responses
2. Validate emotional and behavioral responses as natural, normal, common
3. Assess patient’s primary concern and goals
4. Activity scheduling: They should be actions that are the most important for the patient right
now, not something extra or additional. Activity scheduling can include a blend of activities
that focus on:
- Feeling prepared for surgery
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- Improving physical or emotional well-being
- Coping with anxiety and uncertainty
- Establishing habits to continue after surgery.
5. Assist with problem-solving and helping patients communicate with medical team as needed
Operative Period: Hospitalization for surgery is very disruptive for patients and their families. BA
during this period should continue to be concrete, realistic, and take into account the patient’s current
circumstances.
1. Assess emotional and behavioral responses
2. Validate emotional and behavioral responses as natural, normal, common
3. Assess patient’s primary concern and goals
4. Assist with problem-solving with the patient and family and assist in communicating with their
inpatient and transitional provider team if needed
5. Activity scheduling: should be compatible with treatment goals from other disciplines and
should be able to be safely performed by the patient. They should be actions that are the most
important for the patient right now, not something extra or additional.
Post-Operative Period: Behavioral Activation at this time should assist the patient in their individual
recovery, returning to meaningful activities, and in restoring their sense of self. The interventionist
should be aware of the patient’s discharge instructions, restrictions, and need for follow-up care.
1. Assess emotional and behavioral responses
2. Validate emotional and behavioral responses as natural, normal, common.
3. Assess patient’s primary concern and goals
4. If there are treatment goals from other disciplines that are important for the patient’s
recovery but aren’t being implemented by the patient (e.g., attending physical therapy), the
interventionist should discuss this with the patient:
- Assess and problem-solve barriers
- Clarify misunderstandings
- Frame the importance of the treatment in the context of the patient’s long-term
goals and values.
5. Activity scheduling: should continue to be collaborative and focused on the patient’s longterm goals and values. Activity scheduling can include a blend of activities that focus on:
- physical recovery
returning to previous functioning
- promotion of psychological well-being.
Addressing Barriers: Through the duration of the intervention, the Perioperative Wellness Partner
should assist the patient in anticipating and responding to barriers. Below is a listing of types of
barriers and potential solutions.
Barrier Type
Potential Solutions
Antecedent failure
Not remembering at all, or not remembering
at the right place and time.
Skills deficit
Lacking the skills or knowledge that are
needed to enact the behavior
Social skills deficit
Lacking social or communication skills that
are needed to enact the behavior

-

Reminders
Arranging the environment

Facilitate learning experiences for needed skills.
Schedule and monitor the learning activities.
- If problem-solving presents as a skills deficit,
structured problem-solving can be done in session.
BA sessions can incorporate social skills training,
including instruction, modeling, role-playing, and
assigning real-world practice.
-
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Extrinsic contingency issue
Occurs when the desired behavior is not
reinforcing, perhaps because of the behavior
itself or the patient’s environment.
Intrinsic contingency issue
Occurs when the patient avoids the desired
behavior because of the emotions that it
causes.

-

-

BMJ Open

Premack’s Principle: Reinforce a less rewarding
behavior by engaging in a more enjoyable behavior
afterwards.
In the short term, an arbitrary reward can be used.
Assist to identify avoidance triggers and patterns.
Validate the emotional response and avoidance as
normal.
Discuss that while negative emotions may make it
harder to engage in the desired behavior, they
probably don’t make it impossible. Discuss acting,
even while experiencing negative emotions.
Connect the activity to the patient’s goals and
values.
Schedule concretely and break task down into
manageable chunks.
Discuss pain and fatigue symptom cycles as they
relate to the patient’s experience.
Discuss activity - rest cycle (pacing) as an
alternative: alternating planned activity with
regular rest periods. Keep track of activity and rest
periods and the impact on pain and fatigue levels.

Pain and/or fatigue
Physical pain and fatigue are common in
medically ill surgical patients. Pain and
fatigue may be caused the surgery,
anesthesia, and co-morbid medical
conditions. Anxiety, depression, and stress
also contribute to pain and fatigue.
Overexertion and inactivity can both
exacerbate pain and fatigue, so achieving a
balance of rest and activity is crucial.
Intervention Conclusion: The study intervention is time-limited, and ends after approximately 90 days
post-operatively.
1. Assist the patient in identifying other supports and resources that will continue past the study
period.
2. Review progress and discuss what practices the patient would like to ‘keep,’ and address any
barriers to doing so.
3. Assess need for ongoing mental health treatment and assist with referrals.
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APPENDIX B Medication Optimization Standard Operating Procedure (SOP)

Center for Perioperative Mental Health Intervention:
Medication Optimization
Part A: Initial Medication Review/Letter to Primary Provider
Step 1: Complete detailed review of patient’s home medications: For each medication, determine the
indication, the duration of use, the dose, and frequency. Ask follow-up questions as needed to: Confirm
compliance of each medication. Assess history of any dose modifications and patient’s perceived
impact. Make sure to specifically ask for any over-the-counter medications or supplements, as well any
as-needed medications.
Step 2: Evaluate the patient’s home medications for any of the medications on the list below. Included
on the list are medications that may be harmful for older adults and are therefore eligible for
deprescribing. These medications can cause decreased energy, cognitive impairment, and increased fall
risk.
MEDICATIONS WITH ANTICHOLINERGIC PROPERTIES: typically, these can be stopped
abruptly
Generic
Brand
Amitriptyline
Elavil
Atropine
Benztropine
Cogentin
Chlorpheniramine*
Actifed, Allergy & Congestion Relief, Chlor-Trimeton, Codeprex, Efidac-24
Chlorpheniramine
Cimetidine
Tagamet
Cyclobenzaprine
Amrix, Fexmid, Flexeril
Cyproheptadine
Periactin
Dexchlorpheniramine
Dicyclomine
Bentyl
Diphenhydramine*
Advil PM, Aleve PM, Bayer PM, Benadryl, Excedrin PM, Nytol, Simply
Sleep, Sominex, Tylenol PM, Unisom
Diphenoxylate
Lomotil
Doxepin
Adapin, Silenor, Sinequan
Fesoterodine
Toviaz
Hydroxyzine
Atarax, Vistaril
Hyoscyamine
Anaspaz, Levbid, Levsin, Levsinex, NuLev
Imipramine
Tofranil
Meclizine
Antivert, Bonine
Orphenadrine
Norflex
Oxybutynin
Ditropan, Oxytrol
Prochlorperazine
Compazine
Promethazine
Phenergan
Pseudoephedrine
Aprodine
HCl/Triprolidine HCl
Scopolamine
Transderm Scop
Tolterodine
Detrol
SEDATIVES – BENZODIAZEPINES: may need tapering unless low-dose/intermittent
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Generic
Brand
Alprazolam
Xanax
Chlordiazepoxide
Librium
Clonazepam
Klonopin
Diazepam
Valium
Estazolam
Prosom
Lorazepam
Ativan
Oxazepam
Serax
Triazolam
Halcion
Temazepam
Restoril, Normison, Planum, Tenox, Temaze
NONBENZODIAZEPINE “Z-DRUGS” SEDATIVES: may need tapering unless lowdose/intermittent
Generic
Brand
Eszopiclone
Lunesta
Zolpidem
Ambien

* Almost all OTC sleep and cold/flu medications contain one of these. Patients will not likely know
these ingredients. Find out if they take OTC sleep/cold medicine and recommend stopping it.
Step 3: Evaluate the patient’s home medications for antidepressants eligible for dose escalation.
Compare each antidepressant medication dosage to therapeutic dose ranges listed in the Lexicomp
database. If a patient’s medication dosage is below the therapeutic dose range, make a note on the
patient’s medication list. Common examples include:
•
•
•
•
•
•
•
•
•

Citalopram: increase to 20mg if dose less than 20mg.
Escitalopram: increase to 10mg if dose less than 10mg.
Sertraline: increase to 50mg if dose less than 50mg.
Fluoxetine: increase to 20mg if dose less than 20mg.
Paroxetine: increase to 20mg if dose less than 20mg.
Duloxetine: increase to 60mg if dose less than 60mg.
Venlafaxine: increase to 150mg if dose less than 150mg.
Vilazodone: titrate (by 10mg/week) to 40mg if dose less than 40mg.
Bupropion: increase total daily dose to 300mg if total daily dose is less than 300mg.

Step 4: If the patient is taking a medication eligible for deprescribing: (a) explain why it may be harmful
and get more clarification, if necessary, about reason for taking. (b) Find out (ask the patient) if they’ve
noticed any problems with gait, cognition, or sedation or confusion. (c) Ask if the patient has any
concerns about stopping the medication (e.g., benzodiazepines). (d) Get feedback from the patient (eg,
willingness to stop). (e) Tell the patient you will discuss with the medication optimization team and
return with official recommendations.(f) Find out who prescribes the medication and get buy-in to
contact the patient’s PCP (and/or the prescriber of the medication).
“Oxybutynin causes fatigue and cognitive problems in older people. Have you noticed any
problems with your concentration, energy, or balance?” “You told me you take it for your
bladder—do you think it’s helping?” “You will think more clearly, have more energy, and have
better balance if you stop it or switch to a different medication that isn’t bad for your brain.”
“What do you think? [if in doubt, ask directly: “would you be willing to stop or switch this
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medication?]” “I will discuss with the medication optimization team and let you know what they
recommend. Is it ok with you if we contact your doctor to discuss these changes?”
Step 5: If the patient is taking an antidepressants eligible for dose escalation: (a) Explain that the dose of
their medication may be more helpful for improving their mood and anxiety if taken at a higher dose. (b)
Ask if they have ever tried taking it at a higher dose and whether they had any side effects or
improvements. (c) Ask if they would have any concerns with increasing the dose. (e) Tell the patient
you will discuss with the medication optimization team and return with official recommendations.(f) Get
buy-in to contact the patient’s PCP (and/or the prescriber of the medication).
“I see that you are taking 75mg of venlafaxine each day, and continue to have anxiety and a low
mood. Venlafaxine works better to manage those symptoms when it is taken at a higher dose,
150mg. Have you ever taken venlafaxine at a dose higher than 75mg? Would you have any
concerns with trying a higher dose to provide better management of your mood and anxiety? I
will discuss with the medication optimization team and let you know what they recommend. Is it
ok with you if we contact your doctor to discuss these changes?”

Step 6: Email medication list to the medication optimization contact (regardless of whether the patient
appears to have any medications that are eligible for optimizing). Give any necessary details about
patient experience, issues with medication compliance, resistance to stopping certain meds, perceived
effectiveness, etc. Note any differences from their medication list in Epic.
Step 7: Upon receiving instructions from the medication optimization contact, contact the patient’s
relevant physician (PCP in most cases) via Epic. For providers outside the WU/BJC Epic instance, a
letter will be sent via fax with a call to the office to confirm receipt.
Step 8: Communicate recommendations for medication optimization to the patient:
1) “As we discussed, your medications can have a huge impact on your energy, fall risk, and brain
function. Our expert in medications in older adults has reviewed your list of medications and
recommends stopping the Oxybutynin because it causes problems in older people. If you stop it,
you will think more clearly, have more energy, and have better balance. We contacted your
doctor and they are on board with this plan”
2) “You told me that you don’t think the Oxybutynin is helping very much anyway, so you can just
stop it immediately. If you notice bladder problems after stopping it, you can try taking a nontoxic alternative.”
3) “Does this plan make sense to you? Do you have any questions?”
4) “Great, stopping the Oxybutynin will definitely help your energy and thinking. That’ll help you
towards your goal of going on evening walks with your wife.”
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Part B: Following Up with the Patient Throughout the CPMH Intervention
Phone calls:
•

Use each phone call to keep an updated list of meds: “Have you had any changes to your
medications since we spoke last?”

•

If new meds have been added, check new meds against the list of medications eligible for
medication optimization. If the patient is on a medication from the medication optimization list,
then go through Step 3 above with the patient, then send update to Medication Optimization
team.

Home visits:
•

Home visits are not required, but if they occur, they provide a good opportunity to compare the
medication list to the actual medication bottles the patient has at home. Confirm that our original
list is correct.

•

If there are changes, check new meds against the list of medications eligible for medication
optimization. Send update to medication optimization team if necessary.

•

Ask if they’ve noticed any changes since the medication was stopped.
“When you were in the hospital, you stopped taking oxybutynin because it causes fatigue and
worsens memory. Since then, have you noticed any improvement in your energy or thinking?”
(If person responds yes, then make sure to respond positively and link this to their goals, eg
“Great – your energy is improved! You’re closer to your goal of taking walks with your wife in
the evening!”
If the person responds no, then still say: “That’s ok – people don’t always notice these
improvements. But I can guarantee you, since you stopped this medication, your brain is
working better.”)

•

Also use a Progress Tracker graph to show the progress made by this medication optimization.
See the example below.
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Part C: Post-operative Check for Resuming Antidepressant Treatment
•
•

•

Check the patient’s MAR in Epic appx 24 hours post-operatively to assess whether the patient’s
antidepressant treatment was held for surgery. If it was held, check to see if it has been re-started.
Current guidelines and practice indicate the discontinuation risks are worse and more likely than
potential impact of SSRIs/SNRIs on bleeding. Patients whose antidepressants are not resumed
risk relapse in depression within 2-6 weeks.
In the event that a held antidepressant is not re-started post-operatively, CPMH pharmacists will
contact the patient’s unit pharmacist.
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